Leading u.s.-based psychedelic healthcare vc fund launches with $35 million raised to tackle the growing global mental health crisis

Chicago, july 15, 2021 /prnewswire/ --  p alo santo , the leading u.s.-based psychedelic investment fund, announced its launch with an initial $35 million in capital raised and an active portfolio of 20 companies. the diversified venture fund is focused on tackling the growing global mental health crisis by investing in innovative psychedelic-based and adjacent therapies that are poised to shape the future of psychiatry and fields beyond.
ATAI Ratings Summary
ATAI Quant Ranking